Recent Advances In Endocrinology: South Asian consensus guideline: Use of GLP-1 receptor agonists during Ramadan: Update 2016 Revised Guidelines on the use of GLP-1A in RamadanFaruque Pathan, Zafar Ahmed Latif, Rakesh Kumar Sahay, Abdul Hamid Zargar, Syed Abbas Raza, Azad Khan, Nazrul Islam Siddiqui, Feroz Amin, Noel Somasundaram, Dina Shrestha, Sanjay Kalra.
This guidance is an update to the South Asian Consensus Guideline: Use of GLP1RA in Diabetes during Ramadan, published in the Indian Journal of Endocrinology and Metabolism in 2012. A five country working group has collated evidence and experience to suggest guidelines for the safe and rational use of glucagon-like peptide1 receptor agonists during Ramadan. The suggestions contained herewith are based upon recently published evidence as well as available basic pharmacological data.
Dulaglutide, Exenatide QW, GLP1RA, Hypoglycaemia, Liraglutide, Lixisenatide, Ramadan, South Asia